[1] |
Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.
Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study
[J]. Journal of International Oncology, 2024, 51(6): 326-331.
|
[2] |
Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.
Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer
[J]. Journal of International Oncology, 2024, 51(6): 332-337.
|
[3] |
Qian Xiaotao, Shi Ziyi, Hu Ge.
A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2024, 51(3): 151-156.
|
[4] |
Lyu Lu, Sun Pengfei.
Gut flora and cervical cancer
[J]. Journal of International Oncology, 2023, 50(6): 373-376.
|
[5] |
Radiation Oncology Treatment Physician Branch, Chinese Medical Doctor Association, Radiation Oncology Therapy Branch, Chinese Medical Association, Chinese Association of Radiation Therapy, China Anti-Cancer Association.
Chinese experts' consensus on the application of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy (2023 version)
[J]. Journal of International Oncology, 2023, 50(4): 193-201.
|
[6] |
Zhao Yongrui, Gao Ying, Chen Yidong, Xu Jiankun.
Efficacy and safety of linear accelerator-based fractionated stereotactic radiotherapy for small volume brain metastases
[J]. Journal of International Oncology, 2023, 50(3): 138-143.
|
[7] |
Gong Heyi, Yi Yan, Zhang Jian, Li Baosheng.
Management strategies for locally advanced operable esophageal carcinoma achieving clinical complete response after neoadjuvant chemoradiotherapy
[J]. Journal of International Oncology, 2023, 50(12): 745-750.
|
[8] |
Ma Xueyan, Lu Lili, Sun Pengfei.
Advances in the immune microenvironment in cervical cancer
[J]. Journal of International Oncology, 2023, 50(1): 47-50.
|
[9] |
Li Zhilei, Luo Jialin.
Biological indexes for predicting sensitivity of preoperative concurrent chemoradiotherapy for locally advanced rectal cancer
[J]. Journal of International Oncology, 2022, 49(9): 564-567.
|
[10] |
Wu Puyuan, Qi Liang, Wang Tao, Shi Minke, Sun Yuwei, Wang Lifeng, Liu Baorui, Yan Jing, Ren Wei.
Efficacy of postoperative radiotherapy based on modified clinical target volume according to high-frequency recurrence regions in patients with esophageal squamous cell carcinoma
[J]. Journal of International Oncology, 2022, 49(8): 464-472.
|
[11] |
Xiao Nan, Sun Pengfei.
Research progress of oxidative stress in the sensitivity of chemoradiotherapy for gliomas
[J]. Journal of International Oncology, 2022, 49(6): 357-361.
|
[12] |
Xia Lingling, Chen Yongshun, Li Bin, Ning Tingting, Zhang Caiyutian.
Comparison of safety and efficacy between chemoradiotherapy and chemotherapy after R0 resection in pN+ esophageal squamous cell carcinoma patients
[J]. Journal of International Oncology, 2022, 49(6): 334-339.
|
[13] |
Ye Qian, Ling Zhi, Liu Shenxiang, Lu Guotao, Yin Xudong.
Effects of sarcopenia on the clinical efficacy and prognosis of radical radiotherapy in elderly patients with esophageal cancer
[J]. Journal of International Oncology, 2022, 49(4): 199-205.
|
[14] |
Huang Huayu, Song Qibin, Gong Hongyun, Song Jia.
Analysis on the incidence and risk factors of pneumonia in patients with lung cancer receiving thoracic radiotherapy and immunotherapy
[J]. Journal of International Oncology, 2022, 49(12): 718-723.
|
[15] |
Kong Chunyu, Sun Pengfei.
SLC7A11 and glioma
[J]. Journal of International Oncology, 2022, 49(10): 604-607.
|